Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
REGULATORY
Japan Panel Calls for Better Infrastructure to Expand RLT Access
A Cabinet Office expert panel on radiopharmaceuticals on October 1 discussed measures to buttress Japan’s healthcare infrastructure for radioligand therapy (RLT), with medical experts calling for improvements in treatment capacity, staffing, and reimbursement. The discussion covered Novartis’ prostate cancer therapy…
To read the full story
Related Article
- New Radiopharma Action Plan Urges Domestic CDMO Development: Draft
November 13, 2026
- Japan Shifts Mo-99 Supply Strategy toward Stronger Global Procurement: Panel
July 29, 2026
- Radiopharma Group Seeks Faster NHI Coverage for PET Imaging Agents
July 28, 2026
- Japan Panel Seeks Easing of Rules on Radiopharma Research Samples
June 16, 2026
- Japan Launches Panel to Promote Radiopharmaceuticals
April 21, 2026
REGULATORY
- Mumps Shots Gain Strong Backing as Japan Weighs FY2027 NIP Priorities
November 20, 2026
- Lilly’s Oral GLP-1 Obesity Drug Heads to Dec. 2 Panel Review, Eyes Japan First
November 19, 2026
- Pharma Prods LDP to Rethink CEA Expansion, Project Team to Compile Proposal
November 19, 2026
- First Pralia Biosimilars Inching Closer to Japan Approval, 5 Products Lined Up
November 19, 2026
- MHLW Drug Supply Monitoring System Hit by Cyberattack, Possible Data Leak
November 19, 2026





